Cover Image

Neurological Improvement in a Patient with Cerebroretinal Microangiopathy with Calcifications and Cysts-1 Treated with Bevacizumab

Saved in:

Bibliographic Details
Main Authors:	Siefaddeen Sharayah (Author), Shannon C. Agner (Author), Marwan Shinawi (Author), David Rudnick (Author), Soe Mar (Author)
Format:	Book
Published:	Korean Child Neurology Society, 2023-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New‐onset refractory status epilepticus (NORSE) secondary to Bartonella henselae infection in a pediatric patient
by: Siefaddeen Sharayah, et al.
Published: (2023)

Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022)

Microangiopathy
Published: (2012)

A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab
by: Jun Yen Ng BMedSci (Hons), et al.
Published: (2024)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022)

Transplant-associated thrombotic microangiopathy
by: Tomasz Jarmoliński
Published: (2021)

Dentigerous cyst with ameloblastomatous proliferation as well as calcifications: An unusual presentation
by: Shreya S Saha, et al.
Published: (2020)

Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review
by: Federica Pallotti, et al.
Published: (2022)

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016)

Gastrointestinal perforations in a patient treated by Bevacizumab and chemotherapy: Is it an anaphylactic reaction?
by: Wen-Ling Lee, et al.
Published: (2020)

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
by: Yukinobu Watanabe MD, PhD, et al.
Published: (2021)

Bevacizumab for glioblastoma
by: Narita Y
Published: (2015)

Thrombotic microangiopathy in patients with sickle cell disease
by: Gabriella Biasi Carrasco, et al.
Published: (2024)

Extrarenal manifestations of complement mediated thrombotic microangiopathies
by: Johannes eHofer, et al.
Published: (2014)

A new pathological perspective on thrombotic microangiopathy
by: Yong-Jin Kim
Published: (2022)

Histopathological features of thrombotic microangiopathies in renal biopsies
by: Miguel Ernandes Neto, et al.
Published: (2019)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
by: Ana Teresa Domingos, et al.
Published: (2019)

Pneumococcal Induced T-activation with Resultant Thrombotic Microangiopathy
by: J.W. Oliver, et al.
Published: (2010)

Three shades of black - secondary thrombotic microangiopathy
by: Rhituparna Das, et al.
Published: (2022)

The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
by: Jihad Ben Gabr MD, et al.
Published: (2020)

Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization
by: Hongjie Mu, et al.
Published: (2018)

Managing Epstein-Barr Virus-driven thrombotic microangiopathy in a teenage girl with HIV and previously treated lymphoma
by: Rachit Khandelwal, et al.
Published: (2024)

Transplant associated thrombotic microangiopathy: A transplanter 'S nightmare
by: Sunisha Arora, et al.
Published: (2024)

Drug-induced aortitis in a patient with ovarian cancer treated with bevacizumab combination therapy
by: Kengo Hiranuma, et al.
Published: (2018)

Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
by: Tae Hyun Kim, et al.
Published: (2023)

EXTENSIVE INTRACRANIAL CALCIFICATION WITH NEUROLOGICAL AND OPHTHALMOLOGICAL COMPLICATIONS IN A PATIENT WITH IDIOPATHIC HYPOPARATHYROIDISM: A CASE REPORT
by: Maya P. Danovska, et al.
Published: (2018)

Prevesical Calcification and Hydronephrosis in a Girl Treated for Vesicoureteral Reflux
by: Sarah Kuipers MD, et al.
Published: (2016)

Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
by: Di Cao, et al.
Published: (2023)

Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer
by: Jeyachandran Dhanapriya, et al.
Published: (2017)

Thrombotic microangiopathy associated with arboviral infection: Report of 3 cases.
by: José Luiz Coelho Júnior, et al.
Published: (2021)

Severe Acral Necrosis Complicating Thrombotic Microangiopathy in Two Toddlers
by: H. Nassih, et al.
Published: (2020)

Thrombotic microangiopathies in critically ill children: The MATUCIP registry in Spain
by: Lorena Bermúdez Barrezueta, et al.
Published: (2023)

Thrombotic microangiopathy resulting from neglected blood pressure control
by: Jeong Sang Ku, et al.
Published: (2014)

Emerging Novel Etiology for Thrombotic Microangiopathies: COVID-19 Infection
by: Kübra Kaynar, et al.
Published: (2022)

Thrombotic microangiopathy in a very young infant with mitral valvuloplasty
by: Yuka Matsunaga, et al.
Published: (2018)

Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy
by: Laura Gomez-Ganda, et al.
Published: (2021)

Bevacizumab-Induced Geographic Tongue
by: Marta Martinez-Garcia, et al.
Published: (2021)

Monitoring antiangiogenesis of bevacizumab in zebrafish
by: Zhang J, et al.
Published: (2018)

Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report
by: Han Seul Kim, et al.
Published: (2023)

Exposure-response analysis using time-to-event data for bevacizumab biosimilar SB8 and the reference bevacizumab
by: Suemin Park, et al.
Published: (2024)